Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
33 hedge funds and large institutions have $9.37M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
51% more capital invested
Capital invested by funds: $6.21M → $9.37M (+$3.16M)
3% more funds holding
Funds holding: 32 → 33 (+1)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$25.7K |
| 2 |
HHGC
Hunting Hill Global Capital
New York
|
+$1.41K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$273 |
| 5 |
VF
Virtu Financial
New York
|
+$58 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 2 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$8.09K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$6K |
| 4 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$2.84K |
| 5 |
CAC
Cowen and Company
New York
|
-$776 |
VHAQ.WS Hedge Fund Activity: Q2 2022 in Review
33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q2 2022, worth a combined $9.37M — up 51% from $6.21M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VHAQ.WS positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Radcliffe Capital Management, adding an estimated $25.7K. The largest seller was Citadel Advisors, cutting an estimated $38K.
- 33 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q2 2022, up from 32 in Q1 2022.
- Funds reported $9.37M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q2 2022, up 51% quarter-over-quarter.
- 2 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q2 2022 and 1 closed out, a net change of +1 holder.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q2 2022 was Radcliffe Capital Management, an estimated $25.7K added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q2 2022 was Citadel Advisors, an estimated $38K sold.
Based on aggregated 13F filings for Q2 2022.